Cargando…

Association between effector-type regulatory T cells and immune checkpoint expression on CD8(+) T cells in malignant ascites from epithelial ovarian cancer

BACKGROUND: Regulatory T cells (Tregs) play an important role in the antitumor immune response in epithelial ovarian cancer (EOC). To understand the immune-inhibitory networks of EOC, we addressed the association between Tregs and immune checkpoint expression on T cells in the tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Sho, Matsushita, Hirokazu, Shintani, Daisuke, Kobayashi, Yukari, Fujieda, Nao, Yabuno, Akira, Nishikawa, Tadaaki, Fujiwara, Keiichi, Kakimi, Kazuhiro, Hasegawa, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026673/ https://www.ncbi.nlm.nih.gov/pubmed/35449092 http://dx.doi.org/10.1186/s12885-022-09534-z

Ejemplares similares

Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma
por: Yabuno, Akira, et al.
Publicado: (2020)

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2020)

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
por: Nishikawa, Tadaaki, et al.
Publicado: (2017)

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
por: Ikeda, Yuji, et al.
Publicado: (2020)

A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm
por: Sato, Masakazu, et al.
Publicado: (2021)

Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
por: Sato, Masakazu, et al.
Publicado: (2022)

Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
por: Ogasawara, Aiko, et al.
Publicado: (2020)

Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
por: Wada, Ikuo, et al.
Publicado: (2014)

Advanced Mucinous Adenocarcinoma Arising from a Mature Cystic Teratoma: A Case Report and Literature Review
por: Miyasaka, Aki, et al.
Publicado: (2016)

Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing
por: Jang, Miran, et al.
Publicado: (2015)

CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
por: Sun, Changbo, et al.
Publicado: (2021)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma
por: Beck, Richard J., et al.
Publicado: (2023)

Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells
por: Nagasawa, Saya, et al.
Publicado: (2022)

Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy
por: Nagaoka, Koji, et al.
Publicado: (2020)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites
por: Hrvat, Antonio, et al.
Publicado: (2023)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
por: Yoshida, Hiroyuki, et al.
Publicado: (2015)

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
por: Tsubokura, Misato, et al.
Publicado: (2022)

Ultrastructural observation of filtration membrane in cell‐free and concentrated ascites reinfusion therapy for malignant ascites
por: Koga, Kenichi, et al.
Publicado: (2021)

Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration
por: Kurachi, Makoto, et al.
Publicado: (2011)

Detection and Tracking of NY-ESO-1-Specific CD8(+) T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient
por: Miyai, Manami, et al.
Publicado: (2015)

Ultrasound-Guided Intranodal Lymphangiography With Ethiodized Oil to Treat Chylous Ascites
por: Kitagawa, Sho, et al.
Publicado: (2016)

Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer
por: Ikeda, Yuji, et al.
Publicado: (2017)

A novel scoring method based on RNA‐Seq immunograms describing individual cancer‐immunity interactions
por: Kobayashi, Yukari, et al.
Publicado: (2020)

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
por: Yang, Min, et al.
Publicado: (2020)

Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
por: Kakimi, Kazuhiro, et al.
Publicado: (2020)

Denatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water
por: Futami, Junichiro, et al.
Publicado: (2014)

Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy
por: Hosoi, Akihiro, et al.
Publicado: (2018)

Author Correction: Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy
por: Hosoi, Akihiro, et al.
Publicado: (2023)

Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells
por: Sato, Yasuyoshi, et al.
Publicado: (2020)

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results
por: Hanafusa, Norio, et al.
Publicado: (2017)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma
por: Teshima, Taro, et al.
Publicado: (2022)

Prognosis of ovarian cancer is associated with effector memory CD8(+) T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
por: Lieber, Sonja, et al.
Publicado: (2018)

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing
por: Karasaki, Takahiro, et al.
Publicado: (2017)

The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8(+) T cells
por: Kurachi, Makoto, et al.
Publicado: (2014)

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
por: Nishikawa, Tadaaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f0p1reql9v4gf4sej1kko0m210